Literature DB >> 3257477

Human lymphocytes exposed to low doses of ionizing radiations become refractory to high doses of radiation as well as to chemical mutagens that induce double-strand breaks in DNA.

S Wolff1, V Afzal, J K Wiencke, G Olivieri, A Michaeli.   

Abstract

Human lymphocytes exposed to low doses of ionizing radiation from incorporated tritiated thymidine or from X-rays become less susceptible to the induction of chromatid breaks by high doses of X-rays. This response can be induced by 0.01 Gy (1 rad) of X-rays, and has been attributed to the induction of a repair mechanism that causes the restitution of X-ray-induced chromosome breaks. Because the major lesions responsible for the induction of chromosome breakage are double-strand breaks in DNA, attempts have been made to see if the repair mechanism can affect various types of clastogenic lesions induced in DNA by chemical mutagens and carcinogens. When cells exposed to 0.01 Gy of X-rays or to low doses of tritiated thymidine were subsequently challenged with high doses of tritiated thymidine or bleomycin, which can induce double-strand breaks in DNA, or mitomycin C, which can induce cross-links in DNA, approximately half as many chromatid breaks were induced as expected. When, on the other hand, the cells were challenged with the alkylating agent methyl methanesulfonate (MMS), which can produce single-strand breaks in DNA, approximately twice as much damage was found as was induced by MMS alone. The results indicate that prior exposure to 0.01 Gy of X-rays reduces the number of chromosome breaks induced by double-strand breaks, and perhaps even by cross-links, in DNA, but has the opposite effect on breaks induced by the alkylating agent MMS. The results also show that the induced repair mechanism is different from that observed in the adaptive response that follows exposure to low doses of alkylating agents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257477     DOI: 10.1080/09553008814550401

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  52 in total

Review 1.  Hormesis, an update of the present position.

Authors:  Lennart Johansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-26       Impact factor: 9.236

2.  Nature's chemicals and synthetic chemicals: comparative toxicology.

Authors:  B N Ames; M Profet; L S Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 3.  Dietary carcinogens, environmental pollution, and cancer: some misconceptions.

Authors:  B N Ames; L S Gold
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

4.  Effects of acute low doses of gamma-radiation on erythrocytes membrane.

Authors:  Sherif S Mahmoud; Eman El-Sakhawy; Eman S Abdel-Fatah; Adel M Kelany; Rizk M Rizk
Journal:  Radiat Environ Biophys       Date:  2010-09-24       Impact factor: 1.925

Review 5.  Studies of the dose-effect relation.

Authors:  A M Kellerer
Journal:  Experientia       Date:  1989-01-15

Review 6.  Systems biology and its potential role in radiobiology.

Authors:  Ludwig Feinendegen; Philip Hahnfeldt; Eric E Schadt; Michael Stumpf; Eberhard O Voit
Journal:  Radiat Environ Biophys       Date:  2007-12-18       Impact factor: 1.925

7.  A perspective on the scientific, philosophical, and policy dimensions of hormesis.

Authors:  George R Hoffmann
Journal:  Dose Response       Date:  2009-01-19       Impact factor: 2.658

8.  Sparsely ionizing diagnostic and natural background radiations are likely preventing cancer and other genomic-instability-associated diseases.

Authors:  Bobby R Scott; Jennifer Di Palma
Journal:  Dose Response       Date:  2006-12-21       Impact factor: 2.658

9.  Responses to low doses of ionizing radiation in biological systems.

Authors:  Ludwig E Feinendegen; Myron Pollycove; Charles A Sondhaus
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-07

Review 10.  Radiation risk of tissue late effects, a net consequence of probabilities of various cellular responses.

Authors:  L E Feinendegen
Journal:  Eur J Nucl Med       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.